pharma · Paroxysmal Nocturnal Hemoglobinuria (PNH) · Paroxysmal Nocturnal Haemoglobinuria (PNH) · AKTX
Akari Therapeutics
Akari Therapeutics Plc
Akari Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
London, GB HQ
16 Employees
Public company Type
AKTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- London, GB
- Employees
- 16
- Programs
- 9
- Drugs
- 0
- Patents
- 0
Akari Therapeutics pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Akari Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.